Stay updated with breaking news from Opgen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
OpGen (NASDAQ:OPGN – Get Free Report) and BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings and analyst recommendations. Analyst Recommendations This is a summary of […]
StockNews.com initiated coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research note released on Saturday morning. The brokerage issued a sell rating on the medical research company’s stock. OpGen Stock Performance Shares of OPGN opened at $0.38 on Friday. OpGen has a 1 year low of $0.17 and a 1 year high […]
Sanders Morris Harris LLC boosted its holdings in Precigen, Inc. (NASDAQ:PGEN – Free Report) by 26.2% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 410,000 shares of the biotechnology company’s stock after purchasing an additional 85,000 shares during the quarter. Sanders Morris Harris LLC […]
Sanders Morris Harris LLC increased its stake in Precigen, Inc. (NASDAQ:PGEN – Free Report) by 26.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 410,000 shares of the biotechnology company’s stock after purchasing an additional 85,000 shares during the quarter. Sanders Morris Harris LLC […]
StockNews.com began coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a report released on Friday morning. The brokerage issued a sell rating on the medical research company’s stock. Separately, HC Wainwright lowered OpGen from a buy rating to a neutral rating in a research note on Monday, August 14th. Check Out Our Latest […]